Iliofemoral endarterectomy associated with systematic iliac stent grafting for the treatment of severe iliofemoral occlusive disease

被引:13
|
作者
Maitrias, Pierre [1 ,2 ,3 ]
Deltombe, Gwendoline [1 ]
Molin, Valerie [1 ]
Reix, Thierry [1 ,2 ]
机构
[1] Amiens Univ Hosp, Dept Vasc Surg, Ave Laennec Salouel, F-80054 Amiens, France
[2] Jules Verne Univ Picardie, Coll Med, Amiens, France
[3] Univ Hlth Res Ctr, INSERM, Unit 1088, Pathophysiol Mech & Consequences Cardiovasc Calci, Amiens, France
关键词
COMMON FEMORAL-ARTERY; ENDOVASCULAR TREATMENT; AORTOBIFEMORAL BYPASS; SURGICAL-MANAGEMENT; RECONSTRUCTION; ANGIOPLASTY; BIFURCATION; SOCIETY; LESIONS;
D O I
10.1016/j.jvs.2016.07.130
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Iliofemoral endarterectomy with external iliac artery (EIA) stent grafting can be an alternative to traditional open surgery in patients with severe iliac occlusive disease extending to the common femoral artery. We report the midterm outcomes of this approach. Methods: Between 2009 and 2015, 108 patients (76% male; median age, 63 years) underwent a total of 127 iliofemoral endarterectomies combined with EIA stent grafting. Indications were claudication in 60%, rest pain in 20%, ulceration in 15%, and acute ischemia in 5%. Lesions exclusively involved only the EIA segment in 40% of cases, with occlusion in 28%. Lesions involved both the EIA and common iliac artery segments in 49% of cases, with 19% of common iliac artery occlusions and 24% of EIA occlusions. Iliac lesions extended into the aortic segment in 11% of cases. Iliofemoral endarterectomy was performed by eversion whenever possible. Deployment of the EIA stent graft systematically incorporated the EIA segment and the proximal end of the endarterectomy. Self-expanding covered stents were calibrated to the diameter of the endarterectomized EIA. Results: The procedure was technically successful in 100% of patients. Median diameter of covered stents was 8 mm (range, 6-10 mm). No intraoperative arterial rupture or dissection was observed. Early reoperations (3%) were performed for bleeding, infection, or thrombosis. Median length of stay was 5 days. No 30-day mortality was observed. Median followup was 30 months (range, 0-6 years), and overall mortality was 13% (due to cancer in half of the cases). Repeated angioplasty was performed in three (2%) cases, and a subsequent open procedure on the iliofemoral segment was performed in seven (5%) cases. At 2 years, primary patency rate of the treated segment was 91%. The 2-year primary assisted patency and secondary patency rates were 94% and 98%, respectively. Five-year primary, primary assisted, and secondary patency rates were 87%, 92%, and 98%, respectively. Conclusions: Combined iliofemoral endarterectomy and covered stenting of the EIA for treatment of severe occlusive lesions provided acceptable midterm results, probably because of the gain of diameter provided by covered stents. This technique avoids complications due to an aortic or iliac surgical approach and clamping as well as complications related to the presence of a prosthetic implant in an intra-abdominal position.
引用
收藏
页码:406 / 413
页数:8
相关论文
共 50 条
  • [41] Post-Stent Vein Lumen Shape and Clinical Response in Patients Treated for Iliofemoral Venous Occlusive Disease
    Gagne, Paul
    Kuku, Kayode O.
    Mendes, Robert
    Griggs, Amy
    Segbefia, Edem
    Hofmann, Lawrence V.
    Comerota, Anthony
    Garcia-Garcia, Hector M.
    VASCULAR AND ENDOVASCULAR SURGERY, 2025,
  • [42] Percutaneous transluminal angioplasty/stent treatment of totally occlusive iliofemoral artery with limb ischemia: Experience of surgical team
    Ata, Emin Can
    Senel, Muharrem
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 26 (03): : 414 - 421
  • [43] CROSS-OVER GRAFT FOR UNILATERAL OCCLUSIVE DISEASE OF THE ILIOFEMORAL ARTERIES
    MCCAUGHAN, JJ
    KAHN, SF
    ANNALS OF SURGERY, 1960, 151 (01) : 26 - 28
  • [44] The crossover femoropopliteal bypass: A useful option for unilateral iliofemoral occlusive disease
    Chalmers, RTA
    Kerr, J
    Gillies, T
    Brittenden, J
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1996, 11 (03) : 330 - 334
  • [45] Regarding "Descending thoracic aorta to iliofemoral artery bypass grafting: a role for primary revascularization for aortoiliac occlusive disease?" - Reply
    Passman, MA
    Keagy, BA
    JOURNAL OF VASCULAR SURGERY, 2000, 31 (02) : 410 - 411
  • [46] Period frequency of iliofemoral venous occlusive disease by Doppler ultrasound and corresponding treatment in a tertiary care facility
    Crisostomo, Paul R.
    Cho, Jenny
    Feliciano, Beejay
    Klein, Janet
    Jones, Debra
    Dalsing, Michael C.
    JOURNAL OF VASCULAR SURGERY, 2010, 52 (05) : 1272 - 1277
  • [47] AFX unibody stent graft: Effective and safe for the treatment of severe aorto-iliac occlusive disease
    Saricilar, Erin Cihat
    Cain, Justin
    Wang, Cindy
    Fisher, Charles
    Puttaswamy, Vikram
    VASCULAR, 2024, 32 (05) : 1015 - 1025
  • [48] Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease
    Jost, CJ
    Gloviczki, P
    Cherry, KJ
    McKusick, MA
    Harmsen, WS
    Jenkins, GD
    Bower, TC
    JOURNAL OF VASCULAR SURGERY, 2001, 33 (02) : 320 - 327
  • [49] Popliteal access for iliofemoral occlusive disease in the office-based catheter laboratory
    Shennib, Hani
    Teribery, Emily
    Evans, Amanda
    Huerta, Victor
    JOURNAL OF VASCULAR SURGERY, 2025, 81 (01) : 165 - 171
  • [50] Percutaneous transradial coronary angiography and angioplasty in patients with occlusive atherosclerotic iliofemoral disease
    Kelbæk, H
    Vogt, K
    Nielsen, T
    Jorgensen, E
    Kastrup, J
    Saunamäki, K
    Madsen, JK
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2000, 34 (01) : 84 - 86